MUMBAI — The regulatory landscape for celebrity endorsements in India is facing a watershed moment as state authorities crack down on high-profile marketing campaigns. Maharashtra’s newly empowered food safety chief, Tukaram Mundhe, has cast a wide net in an aggressive public health drive, targeting not only defaulting restaurant chains and major grocery warehouses but also some of Bollywood's biggest A-listers. In a move that signals a zero-tolerance policy toward deceptive marketing, notices have been served to superstar Shah Rukh Khan, veteran actor Ajay Devgn, and action star Tiger Shroff over their endorsement of Vimal cardamom products.
According to official notices made public over the weekend, the state Food and Drug Administration (FDA) has flagged these advertisements as classic examples of surrogate marketing. While the actors officially promote cardamom, regulatory authorities argue that the brand name and identity are inextricably linked to a prohibited beetle nut and pan masala mix. These tobacco-adjacent products are widely sold across India in tiny, affordable ₹3.5 packs, making them highly accessible to vulnerable demographics. Industry estimates underscore the massive scale of this commercial ecosystem, valuing India's pan masala market at a staggering $5 billion last year alone.
Health experts and medical professionals have long warned that the consumption of pan masala and its derivatives is a leading cause of oral fibrosis, a debilitating condition that frequently progresses to oral cancer. Despite these severe public health implications, surrogate advertising has remained a persistent loophole for brands looking to bypass direct bans on tobacco and gutkha marketing. In one particularly high-profile Vimal cardamom campaign, Khan, Devgn, and Shroff are featured in a vibrant festive celebration throwing saffron, a commercial that has already garnered over 106 million views on YouTube. Representatives for the Bollywood stars, as well as Vishnu & Company Trademarks—the parent company owning the Vimal brand—have thus far declined to respond to media requests for comment.
The Maharashtra FDA's notice explicitly states that such strategic use of brand identities maintains consumer recognition of prohibited substances, effectively normalizing and reinforcing harmful habits. The actors have been given a strict 15-day window to provide a formal explanation. This regulatory push in Maharashtra mirrors broader national conversations regarding deceptive advertising. Back in 2024, reports surfaced that Indian regulators were drafting stricter legal frameworks to bar surrogate ads entirely, following public complaints against liquor companies utilizing club glasses, soda brands, and music CDs to indirectly market alcoholic beverages. Although those national guidelines are yet to be finalized, state-level enforcers like Mundhe are taking proactive measures to close the compliance gap.
For the broader business, retail, and marketing ecosystems, this crackdown serves as a severe warning shot. Brands and celebrity management agencies must urgently re-evaluate their endorsement portfolios, shifting away from grey-market surrogate strategies toward transparent, socially responsible business practices. As consumer awareness grows and regulatory bodies tighten their grip, the era of unvetted celebrity brand endorsements is drawing to a definitive close, forcing companies to prioritize long-term consumer health over short-term promotional gains.
"The aggressive regulatory crackdown by the Maharashtra FDA marks a critical turning point for the Indian advertising and business ecosystem. Celebrity endorsements carry immense influence, and with that power comes profound corporate and social responsibility. When mainstream stars lend their faces to surrogate products linked to hazardous substances like pan masala, it not only breaches ethical marketing standards but also invites severe regulatory backlash. At StartupLanes, we firmly believe that the future of brand building must be anchored in absolute transparency and compliance. Founders, marketers, and celebrity managers must recognize that the era of exploiting legal loopholes through surrogate advertising is rapidly coming to an end. Businesses must pivot toward authentic value creation and socially conscious branding that prioritizes public health over short-term commercial gains." — Dr. Shishir Gupta, Founder & CEO, StartupLanes
